These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11578105)

  • 1. Iontophoretic pulsatile transdermal delivery of human parathyroid hormone (1-34).
    Suzuki Y; Iga K; Yanai S; Matsumoto Y; Kawase M; Fukuda T; Adachi H; Higo N; Ogawa Y
    J Pharm Pharmacol; 2001 Sep; 53(9):1227-34. PubMed ID: 11578105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34).
    Suzuki Y; Nagase Y; Iga K; Kawase M; Oka M; Yanai S; Matsumoto Y; Nakagawa S; Fukuda T; Adachi H; Higo N; Ogawa Y
    J Pharm Sci; 2002 Feb; 91(2):350-61. PubMed ID: 11835195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronically facilitated transdermal delivery of human parathyroid hormone (1-34).
    Medi BM; Singh J
    Int J Pharm; 2003 Sep; 263(1-2):25-33. PubMed ID: 12954177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and hepatic extraction of recombinant human parathyroid hormone, hPTH (1-34), in rat, dog, and monkey.
    Jones KO; Owusu-Ababio G; Vick AM; Khan MA
    J Pharm Sci; 2006 Nov; 95(11):2499-506. PubMed ID: 16886208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats.
    Agu RU; Valiveti S; Earles DC; Klausner M; Hayden PJ; Wermeling DP; Stinchcomb AL
    Endocr Res; 2004 Aug; 30(3):455-67. PubMed ID: 15554361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones.
    Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
    J Control Release; 2000 May; 66(2-3):127-33. PubMed ID: 10742574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new immunoenzymometric assay for bioactive N-terminal human parathyroid hormone fragments and its application in pharmacokinetic studies in dogs.
    Mägerlein M; Hock D; Adermann K; Müller-Beckmann B; Neidlein R; Forssmann WG; Stein K
    Arzneimittelforschung; 1998 Feb; 48(2):199-204. PubMed ID: 9541733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.
    Nakamura K; Katagai K; Mori K; Higo N; Sato S; Yamamoto K
    Int J Pharm; 2001 May; 218(1-2):93-102. PubMed ID: 11337153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
    Stevenson RW; Parsons JA
    J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
    J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoresis of dexamethasone sodium phosphate in vitro and in vivo: effect of experimental parameters and skin type on drug stability and transport kinetics.
    Cázares-Delgadillo J; Balaguer-Fernández C; Calatayud-Pascual A; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2010 Jun; 75(2):173-8. PubMed ID: 20332024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
    Ita KB; Banga AK
    Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34).
    Kawane T; Terashima S; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
    Endocrine; 2004 Jul; 24(2):121-9. PubMed ID: 15347837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.
    Dobnig H; Turner RT
    Endocrinology; 1997 Nov; 138(11):4607-12. PubMed ID: 9348185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of a approximately 13 kDa protein--an in vivo comparison of physical enhancement methods.
    Katikaneni S; Li G; Badkar A; Banga AK
    J Drug Target; 2010 Feb; 18(2):141-7. PubMed ID: 19772395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.